Jennifer Lynn Minai-azary - Net Worth and Insider Trading

Jennifer Lynn Minai-azary Net Worth

The estimated net worth of Jennifer Lynn Minai-azary is at least $68,400 dollars as of 2024-05-15. Jennifer Lynn Minai-azary is the CFO of Context Therapeutics Inc and owns about 40,000 shares of Context Therapeutics Inc (CNTX) stock worth over $68,400. Details can be seen in Jennifer Lynn Minai-azary's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer Lynn Minai-azary has not made any transactions after 2022-12-16 and currently still holds the listed stock(s).

Transaction Summary of Jennifer Lynn Minai-azary

To

Jennifer Lynn Minai-azary Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer Lynn Minai-azary owns 2 companies in total, including Tempest Therapeutics Inc (TPST) , and Context Therapeutics Inc (CNTX) .

Click here to see the complete history of Jennifer Lynn Minai-azary’s form 4 insider trades.

Insider Ownership Summary of Jennifer Lynn Minai-azary

Ticker Comapny Transaction Date Type of Owner
TPST Tempest Therapeutics Inc 2021-02-01 Chief Financial Officer
CNTX Context Therapeutics Inc 2022-12-16 Chief Financial Officer

Jennifer Lynn Minai-azary Latest Holdings Summary

Jennifer Lynn Minai-azary currently owns a total of 1 stock. Jennifer Lynn Minai-azary owns 40,000 shares of Context Therapeutics Inc (CNTX) as of December 16, 2022, with a value of $68,400.

Latest Holdings of Jennifer Lynn Minai-azary

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNTX Context Therapeutics Inc 2022-12-16 40,000 1.71 68,400

Holding Weightings of Jennifer Lynn Minai-azary


Jennifer Lynn Minai-azary Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer Lynn Minai-azary has made a total of 2 transactions in Context Therapeutics Inc (CNTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Context Therapeutics Inc is the acquisition of 25,000 shares on December 16, 2022, which cost Jennifer Lynn Minai-azary around $18,500.

Insider Trading History of Jennifer Lynn Minai-azary

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer Lynn Minai-azary Trading Performance

GuruFocus tracks the stock performance after each of Jennifer Lynn Minai-azary's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer Lynn Minai-azary is -21.86%. GuruFocus also compares Jennifer Lynn Minai-azary's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer Lynn Minai-azary within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jennifer Lynn Minai-azary's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jennifer Lynn Minai-azary

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.18
Relative Return to S&P 500(%) -7.39

Jennifer Lynn Minai-azary Ownership Network

Ownership Network List of Jennifer Lynn Minai-azary

No Data

Ownership Network Relation of Jennifer Lynn Minai-azary


Jennifer Lynn Minai-azary Owned Company Details

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Jennifer Lynn Minai-azary is the Chief Financial Officer of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include Corporate Controller Justin Trojanowski , VP of Strategy and Finance Nicholas Maestas , and 10 percent owner Versant Side Fund Iv, L.p. .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tempest Therapeutics Inc (TPST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tempest Therapeutics Inc Insider Transactions

No Available Data

Jennifer Lynn Minai-azary Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer Lynn Minai-azary. You might contact Jennifer Lynn Minai-azary via mailing address: 110 Miller Avenue, Suite 100, Ann Arbor Mi 48104.

Discussions on Jennifer Lynn Minai-azary

No discussions yet.